We are pleased to announce the appointment of John Van Der Wielen to our Board of Directors. His extensive accomplishments in corporate strategy across diverse industries, including the health industry, plus his proven track record of driving growth and innovation, makes him a valuable asset to the company’s leadership team.
As we welcome John to the board, we are confident that his contributions will play a critical role in guiding our company towards new heights of achievement. We look forward to benefiting from his insights and leadership.
#PerthPharma #CDMO #NovaCina #BridgewestPerthPharma #LumaCina